Giulia C. Kennedy - Nov 4, 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Nov 4, 2022
Transactions value $
-$25,575
Form type
4
Date filed
11/8/2022, 04:44 PM
Previous filing
Sep 7, 2022
Next filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Sale -$25.6K -1.02K -1.48% $25.00 68K Nov 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.